← Back to search

Protein Structures and Oligomeric States

Enter a protein name, UniProt accession or PDB ID. Name searches ask you to confirm the protein identity before related structures are queried.

Current Protein Identity：P04591 New Search
19PDB entries
26Biological assembly
99chain/assembly records
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1E6J Crystal structure of HIV-1 capsid protein (p24) in complex with Fab13B5 Deposited 2000-08-18 Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain P 143–352（210 aa） Fragment：GAG POLYPROTEIN RESIDUES 143-352
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；277 K；PROTEIN AT 7MG/ML IN 7% PEG8000, 0.1M TRIS-HCL PH=7.5, 5MM DTT, 0.5MM K2PTCL4 AT 4C USING THE HANGING DROP SYSTEM, pH 7.50
Resolution 3.00 Å R-free 0.284
1TSQ CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT Deposited 2004-06-21 Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain P 428–437（10 aa）
Mutation：AP2V ACT ACETATE ION × 10 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.2；298 K；SODIUM PHOSPHATE, SODIUM CITRATE, AMMONIUM SULPHATE, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.00 Å R-free 0.231
1TSU CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT Deposited 2004-06-21 Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain P 428–434（7 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.2；298 K；SODIUM PHOSPHATE, SODIUM CITRATE, AMMONIUM SULPHATE, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.234
5I1R Quantitative characterization of configurational space sampled by HIV-1 nucleocapsid using solution NMR and X-ray scattering Deposited 2016-02-05 Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain A 378–432（55 aa）
Not recorded ZN ZINC ION × 2 Not declared
NMR measurement conditions pH 6.5；308 K；Ionic strength (raw mmCIF value) 50；Pressure 1
NMR sample composition 0.2 mM [U-13C; U-15N; U-2H] Nucleocapsid protein of human immunodeficiency virus 1 (HIV-1), 50 mM sodium chloride, 20 mM sodium phosphate, 1 mM Dithiothreitol, 0.1 mM zinc chloride, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR sample composition 0.2 mM [U-13C; U-15N; U-2H] Nucleocapsid protein of human immunodeficiency virus 1 (HIV-1), 50 mM sodium chloride, 20 mM sodium phosphate, 1 mM Dithiothreitol, 0.1 mM zinc chloride, 5 % neutral bicelles, 93% H2O/7% D2O | 93% H2O/7% D2O
Resolution not provided
6CPL Crystal structure of DR11 presenting the gag293 epitope Deposited 2018-03-13 Assembly 1 Other combination Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain C 293–312（20 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SO4 SULFATE ION × 5 NA SODIUM ION × 3 ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；PEG 3350, Tris pH 8.5, Ethylene glycol
Resolution 2.45 Å R-free 0.253
6CPN Crystal structure of DR11 presenting the RQ13 peptide Deposited 2018-03-13 Assembly 1 Other combination Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain C 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SO4 SULFATE ION × 8 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；ammonium sulfate, HEPES pH 7.5, PEG 4000
Resolution 2.00 Å R-free 0.236
6CPO Crystal structure of DR15 presenting the RQ13 peptide Deposited 2018-03-13 Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain C 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 PGE TRIETHYLENE GLYCOL × 1 PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；PBS pH 7.5, Na acetate, PEG 4000
Resolution 2.40 Å R-free 0.246
6CPO Crystal structure of DR15 presenting the RQ13 peptide Deposited 2018-03-13 Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain F 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；PBS pH 7.5, Na acetate, PEG 4000
Resolution 2.40 Å R-free 0.246
6CQJ Crystal structure of DR1 presenting the RQ13 peptide Deposited 2018-03-15 Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain C 299–311（13 aa）
Not recorded PEG DI(HYDROXYETHYL)ETHER × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；HEPES pH 7.5, Na acetate, PEG 4000
Resolution 2.75 Å R-free 0.249
6CQJ Crystal structure of DR1 presenting the RQ13 peptide Deposited 2018-03-15 Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain F 299–311（13 aa）
Not recorded PEG DI(HYDROXYETHYL)ETHER × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；HEPES pH 7.5, Na acetate, PEG 4000
Resolution 2.75 Å R-free 0.249
6CQJ Crystal structure of DR1 presenting the RQ13 peptide Deposited 2018-03-15 Assembly 3 Other combination Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain I 299–311（13 aa）
Not recorded PEG DI(HYDROXYETHYL)ETHER × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；HEPES pH 7.5, Na acetate, PEG 4000
Resolution 2.75 Å R-free 0.249
6CQL Crystal structure of F24 TCR -DR11-RQ13 peptide complex Deposited 2018-03-15 Assembly 1 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count
Chain C 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 MG MAGNESIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；Tris-HCl pH 8, NaCl, PEG 3350
Resolution 2.40 Å R-free 0.256
6CQN Crystal structure of F5 TCR -DR11-RQ13 peptide complex Deposited 2018-03-15 Assembly 1 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count
Chain C 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SO4 SULFATE ION × 4 CL CHLORIDE ION × 2 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；MgCl, Am SO4,PEG 3350
Resolution 2.50 Å R-free 0.251
6CQQ Crystal structure of F24 TCR -DR15-RQ13 peptide complex Deposited 2018-03-16 Assembly 1 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count
Chain C 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 MG MAGNESIUM ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；PEG 4000, AmSO4, MgCl
Resolution 2.80 Å R-free 0.254
6CQQ Crystal structure of F24 TCR -DR15-RQ13 peptide complex Deposited 2018-03-16 Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count
Chain H 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；PEG 4000, AmSO4, MgCl
Resolution 2.80 Å R-free 0.254
6CQR Crystal structure of F24 TCR -DR1-RQ13 peptide complex Deposited 2018-03-16 Assembly 1 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count
Chain C 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；Tris-HCl pH 8, NaCl PEG 3350
Resolution 3.04 Å R-free 0.254
6CQR Crystal structure of F24 TCR -DR1-RQ13 peptide complex Deposited 2018-03-16 Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count
Chain H 299–311（13 aa）
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；Tris-HCl pH 8, NaCl PEG 3350
Resolution 3.04 Å R-free 0.254
6EC2 Structure of HIV-1 CA 1/3-hexamer Deposited 2018-08-07 Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain A 133–363（231 aa）
Chain G 133–363（231 aa）
Mutation：E45C, T54E, W184A, M185A Mutation：A14C, A42E, W184A, M185A ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions MICROBATCH；pH 6；293 K；0.2M Calcium Acetate, 0.1 M MES:NaOH pH 6, 20% PEG 8000
Resolution 3.40 Å R-free 0.275
6EC2 Structure of HIV-1 CA 1/3-hexamer Deposited 2018-08-07 Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain C 133–363（231 aa）
Chain F 133–363（231 aa）
Mutation：A14C, A42E, W184A, M185A Mutation：E45C, T54E, W184A, M185A ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions MICROBATCH；pH 6；293 K；0.2M Calcium Acetate, 0.1 M MES:NaOH pH 6, 20% PEG 8000
Resolution 3.40 Å R-free 0.275
6ECN HIV-1 CA 1/2-hexamer-EE Deposited 2018-08-08 Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain A 133–363（231 aa）
Chain B 133–363（231 aa）
Mutation：E45C, T54C, W184A, M185A Mutation：A42C, T54E, W184A, M185A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions MICROBATCH；293 K；0.1M Sodium Citrate pH 5, 8% PEG 8000
Resolution 3.40 Å R-free 0.275
6ECN HIV-1 CA 1/2-hexamer-EE Deposited 2018-08-08 Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric（3） Consistent with protein count
Chain D 133–363（231 aa）
Chain E 133–363（231 aa）
Mutation：E45C, T54C, W184A, M185A Mutation：A42C, T54E, W184A, M185A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions MICROBATCH；293 K；0.1M Sodium Citrate pH 5, 8% PEG 8000
Resolution 3.40 Å R-free 0.275
6ECO Hexamer-2-Foldon HIV-1 capsid platform Deposited 2018-08-08 Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain A 133–358（226 aa）
Chain D 133–353（221 aa）
Mutation：E45C, T54E Mutation：A14C, A42E, A204D No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions MICROBATCH；pH 7.5；293 K；0.2M Sodium Chloride, 0.1M HEPES pH 7.5, 12% PEG 8000
Resolution 4.20 Å R-free 0.316
9CWV Gag CA-SP1 immature lattice from intact enveloped virus-like particles Deposited 2024-07-30 Assembly 1 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric（18） Consistent with protein count
Chain A 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain B 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain C 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain D 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain E 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain F 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain G 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain H 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain I 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain J 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain K 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain L 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain M 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain N 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain O 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain P 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain Q 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Chain R 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 142-372)
Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I IHP INOSITOL HEXAKISPHOSPHATE × 7 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4；This is the final buffer in which the enveloped viral-like particle was resuspended. The Gag-CA-SP1 lattice is inside the viral-like particle and not directly in this buffer environment.
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.42 Å
9D6C Gag CA-SP1 immature lattice bound with Lenacapavir and Bevirimat from enveloped virus like particles Deposited 2024-08-14 Assembly 1 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: 18-meric（18） Consistent with protein count
Chain A 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain B 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain C 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain D 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain E 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain F 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain G 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain H 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain I 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain J 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain K 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain L 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain M 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain N 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain O 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain P 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain Q 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain R 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I QNG Lenacapavir × 18 2I4 3alpha-[(3-carboxy-3-methylbutanoyl)oxy]-8alpha,9beta,10alpha,13alpha,17alpha,19beta-lup-20(29)-en-28-oic acid × 7 IHP INOSITOL HEXAKISPHOSPHATE × 7 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4；This is the final buffer in which the enveloped viral like particle was resuspended. The Gag-CA-SP1 lattice is inside the viral like particle and thus not in the direct environment of this buffer.
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.10 Å
9DWD Gag CA-SP1 immature lattice bound with Lenacapavir from enveloped virus like particles (T8I) Deposited 2024-10-09 Assembly 1 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric（18） Consistent with protein count
Chain A 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain B 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain C 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain D 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain E 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain F 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain G 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain H 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain I 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain J 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain K 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain L 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain M 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain N 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain O 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain P 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain Q 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Chain R 141–372（232 aa） Fragment：CA-SP1 domains (UNP residues 141-372)
Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I QNG Lenacapavir × 18 IHP INOSITOL HEXAKISPHOSPHATE × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4；This is the final buffer in which the enveloped viral-like particle was resuspended. The Gag-CA-SP1 lattice is inside the viral-like particle and thus not in the direct environment of this buffer.
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.13 Å
9E39 Gag CA-SP1 (T8I) immature lattice bound with Bevirimat from enveloped virus like particles Deposited 2024-10-23 Assembly 1 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric（18） Consistent with protein count
Chain A 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain B 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain C 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain D 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain E 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain F 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain G 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain H 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain I 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain J 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain K 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain L 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain M 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain N 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain O 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain P 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain Q 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Chain R 144–374（231 aa） Fragment：CA-SP1 domains (UNP residues 144-374)
Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I Mutation：T239I 2I4 3alpha-[(3-carboxy-3-methylbutanoyl)oxy]-8alpha,9beta,10alpha,13alpha,17alpha,19beta-lup-20(29)-en-28-oic acid × 1 IHP INOSITOL HEXAKISPHOSPHATE × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4；This is the final buffer in which the enveloped viral like particle was resuspended. The Gag-CA-SP1 lattice is inside the viral like particle and thus not in the direct environment of this buffer.
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.71 Å

This page presents structural evidence recorded in PDB/mmCIF.“No recorded non-water small molecule” does not prove that the experimental sample was ligand-free; experimental conditions belong to the PDB experiment, while ligands and copy counts are shown for each biological assembly.